{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:53:19Z","timestamp":1790776399456,"version":"4.1.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:p>Cervical cancer screening in young women may lead to the detection of lesions with a high potential for spontaneous regression and no benefit of surgery. French guidelines recommend initiating cervical cancer screening by the Pap test from the age of 25 years. To date, no French nationwide study has assessed cervical cancer screening in young women and the related subsequent work-up and surgical procedures among screen-positive women. Using data from the French national healthcare databases (around 50 million beneficiaries), annual and 3-year Pap test screening rates were calculated among women aged 15\u201324 years between 2007 and 2013. Cervical excisional procedures were assessed during the 15-month period following a first Pap test in women aged 20\u201324 years in 2007 and 2012. About 10% of the almost six million women aged 15\u201365 years with at least one annual Pap test were under the age of 25, mainly women aged 20\u201324 years, in whom the 3-year screening coverage was 35.5% in 2013. In screened women aged 20\u201324 years, human papillomavirus testing rates increased markedly over the study period (+105%) and surgical management became less conservative with an increased rate of both conization (+16.5%) and other excisional treatments (+74.5%). Nevertheless, because of the overall decrease in screening coverage, the absolute yearly number of women who underwent conization decreased from 1974 to 1766 between 2007 and 2012. Higher adherence to guidelines is needed to reduce the burden of surgical treatment that is potentially associated with adverse obstetric outcomes among women under the age of 25 years.<\/jats:p>","DOI":"10.1097\/cej.0000000000000360","type":"journal-article","created":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T14:22:33Z","timestamp":1491056553000},"page":"479-485","source":"Crossref","is-referenced-by-count":16,"title":["Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France: a nationwide French healthcare database study"],"prefix":"10.1097","volume":"27","author":[{"given":"G\u00e9ric","family":"Maura","sequence":"first","affiliation":[{"name":"French National Health Insurance (Caisse Nationale de l\u2019Assurance Maladie des Travailleurs Salari\u00e9s, CNAMTS)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Chaignot","sequence":"additional","affiliation":[{"name":"French National Health Insurance (Caisse Nationale de l\u2019Assurance Maladie des Travailleurs Salari\u00e9s, CNAMTS)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Weill","sequence":"additional","affiliation":[{"name":"French National Health Insurance (Caisse Nationale de l\u2019Assurance Maladie des Travailleurs Salari\u00e9s, CNAMTS)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Alla","sequence":"additional","affiliation":[{"name":"French National Health Insurance (Caisse Nationale de l\u2019Assurance Maladie des Travailleurs Salari\u00e9s, CNAMTS)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Heard","sequence":"additional","affiliation":[{"name":"French HPV Reference Laboratory (Centre National de R\u00e9f\u00e9rence des papillomavirus humains), Institut Pasteur"},{"name":"Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re, Public Assistance - Paris Hospitals, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230905","doi-asserted-by":"crossref","first-page":"a1284","DOI":"10.1136\/bmj.a1284","article-title":"Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis","volume":"337","author":"Arbyn","year":"2008","journal-title":"BMJ"},{"key":"R2-20230905","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1016\/j.ejca.2009.07.016","article-title":"The challenges of organising cervical screening programmes in the 15 old member states of the European Union","volume":"45","author":"Arbyn","year":"2009a","journal-title":"Eur J Cancer"},{"key":"R3-20230905","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ypmed.2009.02.021","article-title":"Analysis of 13 million individual patient records pertaining to Pap smears, colposcopies, biopsies and surgery on the uterine cervix (Belgium, 1996\u20132000)","volume":"48","author":"Arbyn","year":"2009b","journal-title":"Prev Med"},{"key":"R4-20230905","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/annonc\/mdp471","article-title":"European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition \u2013 summary document","volume":"21","author":"Arbyn","year":"2010","journal-title":"Ann Oncol"},{"key":"R6-20230905","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1136\/gutjnl-2015-309690","article-title":"Severe intestinal malabsorption associated with olmesartan: a French nationwide observational cohort study","volume":"65","author":"Basson","year":"2016","journal-title":"Gut"},{"key":"R7-20230905","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/AOG.0b013e31826e4609","article-title":"Cervical carcinoma rates among young females in the United States","volume":"120","author":"Benard","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R8-20230905","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1001\/jamaoncol.2016.3609","article-title":"Population-based incidence rates of cervical intraepithelial neoplasia in the human papillomavirus vaccine era","volume":"3","author":"Benard","year":"2017","journal-title":"JAMA Oncol"},{"key":"R9-20230905","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.respe.2013.11.073","article-title":"Cancer incidence and mortality in France over the 1980\u20132012 period: solid tumors","volume":"62","author":"Binder-Foucard","year":"2014","journal-title":"Rev \u00c9pid\u00e9miol Sant\u00e9 Publique"},{"key":"R10-20230905","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1016\/S2352-3026(15)00027-7","article-title":"Risk of bleeding and arterial thromboembolism in patients with non-valvular atrial fibrillation either maintained on a vitamin K antagonist or switched to a non-vitamin K-antagonist oral anticoagulant: a retrospective, matched-cohort study","volume":"2","author":"Bouillon","year":"2015","journal-title":"Lancet Haematol"},{"key":"R11-20230905","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/annonc\/mdg305","article-title":"European Code Against Cancer and scientific justification: third version (2003)","volume":"14","author":"Boyle","year":"2003","journal-title":"Ann Oncol"},{"key":"R12-20230905","doi-asserted-by":"crossref","first-page":"482","DOI":"10.5694\/j.1326-5377.2006.tb00661.x","article-title":"Cervical cancer in Australia and the United Kingdom: comparison of screening policy and uptake, and cancer incidence and mortality","volume":"185","author":"Canfell","year":"2006","journal-title":"Med J Aust"},{"key":"R13-20230905","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1158\/1055-9965.EPI-10-1267","article-title":"Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California","volume":"20","author":"Castle","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R14-20230905","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/j.jcv.2015.11.020","article-title":"Cervical cancer screening of HPV vaccinated populations: cytology, molecular testing, both or none","volume":"76","author":"El-Zein","year":"2016","journal-title":"J Clin Virol"},{"key":"R15-20230905","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"R81-20230905","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/bjc.2011.196","article-title":"Increasing rates of cervical cancer in young women in England: an analysis of national data 1982\u20132006","volume":"105","author":"Foley","year":"2011","journal-title":"Br. J Cancer"},{"key":"R20-20230905","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1468-0009.2011.00652.x","article-title":"Cervical cancer screening in the United States and the Netherlands: a tale of two countries","volume":"90","author":"Habbema","year":"2012","journal-title":"Milbank Q"},{"key":"R21-20230905","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1037\/0278-6133.26.2.192","article-title":"Personal meaning of human papillomavirus and pap test results in adolescent and young adult women","volume":"26","author":"Kahn","year":"2007","journal-title":"Health Psychol"},{"key":"R22-20230905","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1097\/LGT.0b013e3182854399","article-title":"Five-year risk of CIN 3+ to guide the management of women aged 21 to 24 years","volume":"17","author":"Katki","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"R23-20230905","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1586\/14737159.2015.1012068","article-title":"Natural history of high-grade cervical intraepithelial neoplasia: a review of prognostic biomarkers","volume":"15","author":"Koeneman","year":"2015","journal-title":"Expert Rev Mol Diagn"},{"key":"R24-20230905","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(06)68181-6","article-title":"Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis","volume":"367","author":"Kyrgiou","year":"2006","journal-title":"Lancet"},{"key":"R27-20230905","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/AOG.0b013e3182883a34","article-title":"Population-based incidence rates of cervical intraepithelial","author":"Massad","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R28-20230905","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/S0140-6736(04)17354-6","article-title":"Regression of low-grade squamous intra-epithelial lesions in young women","volume":"364","author":"Moscicki","year":"2004","journal-title":"Lancet"},{"key":"R29-20230905","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/AOG.0b013e3181fe777f","article-title":"Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women","volume":"116","author":"Moscicki","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R30-20230905","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.revmed.2014.11.009","article-title":"French health insurance databases: what interest for medical research?","volume":"36","author":"Moulis","year":"2015","journal-title":"Rev M\u00e9d Interne"},{"key":"R31-20230905","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/jms.9.2.86","article-title":"The cervical cancer screening programme in Norway, 1992\u20132000: changes in Pap smear coverage and incidence of cervical cancer","volume":"9","author":"Nyg\u00e5rd","year":"2002","journal-title":"J Med Screen"},{"key":"R32-20230905","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/fampra\/cmu029","article-title":"Motivators for women to attend cervical screening: the influential role of GPs","volume":"31","author":"O\u2019Connor","year":"2014","journal-title":"Fam Pract"},{"key":"R33-20230905","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/NCC.0000000000000156","article-title":"Determinants of uptake of cervical cancer screening services at a no-cost reproductive health clinic managed by nurse-midwives","volume":"38","author":"Osingada","year":"2015","journal-title":"Cancer Nurs"},{"key":"R34-20230905","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(04)16674-9","article-title":"The cervical cancer epidemic that screening has prevented in the UK","volume":"364","author":"Peto","year":"2004","journal-title":"Lancet"},{"key":"R35-20230905","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/pds.3879","article-title":"Brand name to generic substitution of antiepileptic drugs does not lead to seizure-related hospitalization: a population-based case-crossover study","volume":"24","author":"Polard","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R36-20230905","doi-asserted-by":"crossref","first-page":"b2968","DOI":"10.1136\/bmj.b2968","article-title":"Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data","volume":"339","author":"Sasieni","year":"2009","journal-title":"BMJ"},{"key":"R37-20230905","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/jfprhc-2015-101170","article-title":"Impact of post-colposcopy management on women\u2019s long-term worries: results from the UK population-based TOMBOLA trial","volume":"42","author":"Sharp","year":"2016","journal-title":"J Fam Plann Reprod Health Care"},{"key":"R39-20230905","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.respe.2010.04.005","article-title":"French national health insurance information system and the permanent beneficiaries sample","volume":"58","author":"Tuppin","year":"2010","journal-title":"Rev \u00c9pid\u00e9miol Sant\u00e9 Publique"},{"key":"R41-20230905","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/CEJ.0000000000000155","article-title":"Cervical cancer screening in Belgium and overscreening of adolescents","volume":"25","author":"Van Kerrebroeck","year":"2016","journal-title":"Eur J Cancer Prev"},{"key":"R42-20230905","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/pds.2044","article-title":"Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitus","volume":"19","author":"Weill","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008469-201809000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T23:28:00Z","timestamp":1693956480000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008469-201809000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000360","relation":{},"ISSN":["0959-8278"],"issn-type":[{"value":"0959-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}